Risk-Based Validation

An approach that scales the depth and rigor of validation evidence to the actual risk a system poses to product quality, patient safety, or record integrity — rather than applying uniform, maximum rigor everywhere.

This is the organizing principle behind FDA’s CSA guidance and behind most modern computerized-systems-assurance programs.